Literature DB >> 27936362

Prevalence of Self-Reported Prescription Drug Use in a National Sample of U.S. Drivers.

Tara Kelley-Baker1, Geetha Waehrer2, Robin A Pollini2.   

Abstract

OBJECTIVE: Drug-involved driving has become an increasing concern. Although the focus has been on illegal drugs, there is evidence that prescribed medications can impair driving ability. The purpose of this study was to determine the self-reported prevalence of prescription drug use, including medical and nonmedical use, among a nationally representative sample of drivers and to report related driver characteristics.
METHOD: As part of the 2013-2014 National Roadside Survey, drivers from 60 sites were randomly recruited and asked to complete a survey on prescription drug use.
RESULTS: Almost 20% of drivers reported using a prescription drug within the past 2 days, with the most common drug class being sedatives (8.0%), followed by antidepressants (7.7%), narcotics (7.5%), and stimulants (3.9%). Drivers who reported prescription drug use were significantly more likely to be female, older, non-Hispanic White, and report disability. Three of four drivers who reported medication use (78.2%) said the drug was prescribed for their use; the odds of using without a prescription were significantly higher for males, Black/African American, and Hispanic drivers, and lower for older drivers. Among those with a prescription, taking more than prescribed was most common for narcotics (6.8%), followed by sedatives (4.8%), stimulants (3.8%), and antidepressants (1.5%).
CONCLUSIONS: These findings help to identify drivers using potentially impairing prescription drugs, both medically and nonmedically, and may inform the targeting of interventions to reduce impaired driving related to medications.

Mesh:

Substances:

Year:  2017        PMID: 27936362      PMCID: PMC5148747          DOI: 10.15288/jsad.2017.78.30

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  20 in total

1.  Changes in the incidence of alcohol-impaired driving in the United States, 1973-1986.

Authors:  A K Lund; A C Wolfe
Journal:  J Stud Alcohol       Date:  1991-07

Review 2.  Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?

Authors:  Silvia Ravera; Johannes G Ramaekers; Lolkje T W de Jong-van den Berg; Johan J de Gier
Journal:  Clin Ther       Date:  2012-05-02       Impact factor: 3.393

3.  Drinking and driving in the United States: the 1996 National Roadside Survey.

Authors:  R B Voas; J Wells; D Lestina; A Williams; M Greene
Journal:  Accid Anal Prev       Date:  1998-03

4.  The prevalence of alcohol use disorders among night-time weekend drivers.

Authors:  C Debra Furr-Holden; Robert B Voas; John Lacey; Eduardo Romano; Kristina Jones
Journal:  Addiction       Date:  2011-05-06       Impact factor: 6.526

5.  Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness.

Authors:  S A Maisto; M P Carey; K B Carey; C M Gordon; J R Gleason
Journal:  Psychol Assess       Date:  2000-06

Review 6.  Benzodiazepines, opioids and driving: an overview of the experimental research.

Authors:  Stefanie Y Leung
Journal:  Drug Alcohol Rev       Date:  2011-05

7.  Effects of opioids on driving ability.

Authors:  T Galski; J B Williams; H T Ehle
Journal:  J Pain Symptom Manage       Date:  2000-03       Impact factor: 3.612

8.  Guidelines for research on drugged driving.

Authors:  J Michael Walsh; Alain G Verstraete; Marilyn A Huestis; Jørg Mørland
Journal:  Addiction       Date:  2008-08       Impact factor: 6.526

Review 9.  Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review.

Authors:  David A Fishbain; R Brian Cutler; Hubert L Rosomoff; Renee Steele Rosomoff
Journal:  J Pain Symptom Manage       Date:  2003-06       Impact factor: 3.612

Review 10.  Driving Under the Influence of Non-Alcohol Drugs--An Update Part I: Epidemiological Studies.

Authors:  H Gjerde; M C Strand; J Mørland
Journal:  Forensic Sci Rev       Date:  2015-07
View more
  6 in total

1.  Receipt of Warnings Regarding Potentially Impairing Prescription Medications and Associated Risk Perceptions in a National Sample of U.S. Drivers.

Authors:  Robin A Pollini; Geetha Waehrer; Tara Kelley-Baker
Journal:  J Stud Alcohol Drugs       Date:  2017-11       Impact factor: 2.582

2.  Pre-Incarceration Rates of Nonmedical Use of Prescription Drugs among Black Men from Urban Counties.

Authors:  Paris Wheeler; Danelle Stevens-Watkins; Joi-Sheree' Knighton; Carlos Mahaffey; Dominiqueca Lewis
Journal:  J Urban Health       Date:  2018-08       Impact factor: 3.671

3.  Prevalence and Predictors of Driving after Prescription Opioid Use in an Adult ED Sample.

Authors:  Aaron D Dora-Laskey; Jason E Goldstick; Brooke J Arterberry; Suni Jo Roberts; Rebecca L Haffajee; Amy S B Bohnert; Rebecca M Cunningham; Patrick M Carter
Journal:  West J Emerg Med       Date:  2020-06-19

4.  Use of Prescription Opioids and Initiation of Fatal 2-Vehicle Crashes.

Authors:  Stanford Chihuri; Guohua Li
Journal:  JAMA Netw Open       Date:  2019-02-01

5.  The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol.

Authors:  C Austin Zamarripa; Matthew D Novak; Elise M Weerts; Ryan Vandrey; Tory R Spindle
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

6.  Medication use and driving patterns in older drivers: preliminary findings from the LongROAD study.

Authors:  Linda L Hill; Howard Andrews; Guohua Li; Carolyn G DiGuiseppi; Marian E Betz; David Strogatz; Patricia Pepa; David W Eby; David Merle; Tara Kelley-Baker; Vanya Jones; Samantha Pitts
Journal:  Inj Epidemiol       Date:  2020-08-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.